Skip Navigation
Skip to contents

J Trauma Inj : Journal of Trauma and Injury

OPEN ACCESS
SEARCH
Search

Best practice

Page Path
HOME > About > Best practice
About
2023

Principles of Transparency and Best Practice in Scholarly Publishing

Posted on February 10, 2023

Journal of Trauma and Injury adheres to the Principles of Transparency and Best Practice in Scholarly Publishing (ver. 4, published September 15, 2022; https://doaj.org/apply/transparency/) developed by Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishing Association (OASPA), and the World Association of Medical Editors (WAME). A compliance checklist of 16 items was used to assess the journal's adherence to the joint statement, as follows:

JOURNAL CONTENT JOURNAL PRACTICES ORGANISATION BUSINESS PRACTICES

JOURNAL CONTENT

1. Name of journal

The official journal title is Journal of Trauma and Injury (abbreviated as J Trauma Inj or JTI).

2. Website

The official website of our journal is https://www.jtraumainj.org/. The JTI team endeavors to make a high-quality website with accurate information and adherence to ethical and professional standards. It does not contain any misleading information, including any attempts to mimic other journal/publisher websites. Detailed information for authors and readers can be found on the journal website, accessible by clicking on the headings below.

3. Publishing schedule

JTI is published quarterly on the last day of March, June, September, and December. Additional supplementary or special issues may also be published.

4. Archiving

JTI is available without barriers through Korea Citation Index and is archived in the National Library of Korea in case the journal is no longer in publication.

5. Copyright

As the official journal of the Korean Society of Traumatology, all published materials in JTI are owned by the Korean Society of Traumatology. All authors must sign the copyright transfer agreement form upon submission. Copyright information is indicated on all published papers (HTML and PDF) and on the JTI website.

6. Licensing

JTI is an open access journal distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, as long as the original work is properly cited. Thus, when using the tables or figures of JTI in other journals or books for scholarly and educational purposes, permission from the publisher of JTI is not necessary. However, for any commercial use of the materials, permission must be obtained from the Korean Society of Traumatology. Licensing information is indicated on all published papers (HTML and PDF) and on the JTI website.

JOURNAL PRACTICES

7. Publication ethics and related editorial policies

JTI follows the Guideline on Good Publication of COPE (https://publicationethics.org/guidance/Guidelines/), Recommendations of International Committee of Medical Journal Editors (https://www.icmje.org/recommendations/), and Good Publication Practice Guidelines for Medical Journals of Korean Association of Medical Journal Editors (https://kamje.or.kr/). Our publication ethics are displayed on the Research and publication ethics section under EDITORIAL POLICY.

In case the journal faces suspected cases of research and publication misconduct, such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, an undisclosed conflict of interest, ethical problems with a submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and so on, the resolution process will follow the flowchart provided by COPE (https://publicationethics.org/guidance/Flowcharts/). The discussion and decision on the suspected cases are carried out by the Editorial Board.

8. Peer review

JTI has an online submission and peer review system at https://submit.jtraumainj.org.

All submitted papers, including those invited by the editor, are subject to peer review. The peer review process also applies to the research data and supplementary materials submitted upon initial submission. Manuscripts not aligning with the aims and scope of JTI or does not adhere to the Instructions for Authors may be promptly returned to the author without review. Prior to peer review, all submissions undergo plagiarism screening using Similarity Check, a plagiarism-detection tool powered by iThenticate (https://www.crossref.org/services/similarity-check/).

JTI follows a double-blind peer review policy, ensuring the anonymity of both authors and throughout the review process. However, the editor managing the review process has access to the identities of both authors and reviewers. Each manuscript undergoes peer review by at least two reviewers with relevant expertise. The Editorial Board selects reviewers based on their expertise, publication history, and past reviews. During the review, reviewers can interact directly with the editor alone (via the submission system or email), following the “independent review” approach. All submissions from editors, employees, or Editorial Board members undergo the same review process, and are not involved in reviewer selection or decision-making. Editors do not handle their own manuscripts even if commissioned. Certain publication types, including editorials, errata, corrigenda, retractions, withdrawals, and letters to the editor, are reviewed by the Editorial Board without external peer review.

The initial decision is typically made within 2 months of receiving a manuscript. If there is no correspondence from the Editorial Office regarding the manuscript’s status after 2 months, authors are encouraged to the contact the Editorial Office. The Editorial Board may request authors to revise their manuscripts based on the reviewers’ feedback. Authors are required to upload the revised manuscripts along with responses to each reviewer's comments. Revisions should be completed within 90 days of the request. Failure to submit a revised manuscript by the due date will result in the Editorial Board not considering it for publication. Authors can request an extension for revisions, which may be granted at the Editorial Board's discretion. The manuscript review process ideally concludes after the second review. However, the Editorial Board may consider additional review rounds at the authors’ request. If necessary, a professional statistical review by a statistician may be conducted. The Editorial Board is responsible for the final decision on whether to accept or reject a manuscript after the peer review.

All published articles in JTI display the dates of submission, revision, acceptance, and publication on their article page, but information regarding the review process and editorial decision are not published. JTI does not guarantee acceptance of initial manuscript submissions except for the invited articles.

Further details on peer review can be found in the Peer review policy page under EDITORIAL POLICY.

9. Access

JTI is freely accessible journal website (https://www.jtraumainj.org/) according to the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/). The copyright, including the right of online transmission, is owned by the Korean Society of Traumatology.

ORGANISATION

10. Ownership and management

The journal is owned by the publisher, the Korean Society of Traumatology (https://www.trauma.or.kr/). The full names and affiliations of the members of the journal management team can be found in the Managing team section under ABOUT.

11. Advisory body

The Editorial Board serves as the journal's advisory body. The names and affiliations of all Editorial Board members are disclosed, and their detailed information can be accessed through links to their ORCID, Research ID, and Scopus ID profiles.

12. Editorial team and contact information

An editorial team in charge of managing and publishing the journal's content is displayed in the Managing team section under ABOUT. Contact information for the Editor-in-Chief and the Editorial Office can be found in the Contact us section under ABOUT.

BUSINESS PRACTICES

13. Author fees

JTI is a platinum open access journal that does not charge author fees. Thus, there are no fees for author submissions or other publication-related charges. The publisher fully covers all costs associated with the publication process.

14. Other revenue

Revenue sources of JTI include support from the publisher, the Korean Society of Traumatology, and a grant from the Korean Federation of Science and Technology Societies, which is funded by the Ministry of Science and ICT of Korea.

15. Advertising

JTI currently does not accept any commercial product advertisements, unless the policy changes otherwise in the future.

16. Direct marketing

Journal propagation is carried out through the journal website and distribution of introduction pamphlets. Invitations to submit a manuscript are usually targeted at presenters of conferences, seminars, or workshops related to the journal's aims and scope.

JTI recognizes the responsibility of publishers and editors to promote accessibility, diversity, equity, and inclusivity in all aspects of publication, as outlined in these principles. Editorial decisions are based solely on scholarly merit and are not influenced by the authors' nationality, ethnicity, political beliefs, race, or religion. JTI is committed to promoting inclusiveness and regularly evaluating its policies to ensure that they do not create an exclusionary environment.


J Trauma Inj : Journal of Trauma and Injury
TOP